Table 2. Final diagnosis of 74 PLLs who underwent rEBUS GS TBLB/TBNA.
| Variables | Values |
|---|---|
| Diagnosed with rEBUS GS TBLB/TBNA (n=52) | |
| Malignant disease, n (%) | 43 (82.7) |
| Adenocarcinoma | 28 (65.1) |
| Squamous cell carcinoma | 9 (20.9) |
| NSCLC NOS | 2 (4.7) |
| Small cell lung cancer | 3 (7.0) |
| Carcinoid | 1 (2.3) |
| Benign disease, n (%) | 9 (17.3) |
| Tuberculosis | 5 (55.6) |
| Aspergillosis | 2 (22.2) |
| Cryptococcosis | 1 (11.1) |
| Organizing pneumonia | 1 (11.1) |
| Undiagnosed with rEBUS GS TBLB/TBNA (n=22) | |
| Malignant disease, n (%) | 4 (18.2) |
| Adenocarcinoma | 1 (25.0) |
| Squamous cell carcinoma | 1 (25.0) |
| Large cell carcinoma | 1 (25.0) |
| Sarcomatoid carcinoma | 1 (25.0) |
| Benign disease, n (%) | 10 (45.5) |
| Tuberculosis | 2 (20.0) |
| NTM | 1 (10.0) |
| Aspergillosis | 1 (10.0) |
| Chronic inflammation | 6 (60.0) |
| Unknown, n (%) | 8 (36.4) |
GS, guide sheath; NSCLC NOS, non-small cell lung cancer not otherwise specified; NTM, non-tuberculous mycobacterium; PLL, peripheral lung lesion; rEBUS, radial endobronchial ultrasound; TBLB, transbronchial lung biopsy; TBNA, transbronchial needle aspiration.